CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics, Inc. (NASDAQ:EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced that Abbie Celniker, PhD, President and Chief Executive Officer, will present a company overview at the 22nd Annual NewsMakers in the Biotech Industry Conference in New York on Thursday, September 10, 2015 at 3:30 p.m. ET.
Help employers find you! Check out all the jobs and post your resume.
